SCHEMBL24908635

SCHEMBL24908635

CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCNC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 7/20 1.00
TSHR P16473 2/20 0.56
ALDH1A1 P00352 1/20 0.56
THRB P10828 1/20 0.53
S1PR2 O95136 5/20 0.50
S1PR4 O95977 5/20 0.50
S1PR1 P21453 5/20 0.50
S1PR3 Q99500 5/20 0.50
S1PR5 Q9H228 1/20 0.50
ADH1B P00325 1/20 0.50
ADH1C P00326 1/20 0.50
ADH1A P07327 1/20 0.50
ADH4 P08319 1/20 0.50
ADH7 P40394 1/20 0.50
PPARA Q07869 2/20 0.44
LPAR3 Q9UBY5 2/20 0.43
LPAR2 Q9HBW0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22223 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2
SCHEMBL22876 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2
SCHEMBL37402 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2
SCHEMBL19711750 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2
SCHEMBL25273267 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2
SCHEMBL117989 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2
SCHEMBL25145215 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2
SCHEMBL577733 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2
SCHEMBL9801380 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2
SCHEMBL23167 1.00 EPHX1 (1.00) EPHX1TSHRALDH1A1THRBS1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11560554-B2 Lysosomal storage disease enzymes ALEXION PHARMACEUTICALS, INC. (US) 2023-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11560554-B2 Lysosomal storage disease enzymes GAA, GBA1, MAN2B1 EPHX1 2785/4885TSHR 1915/4885ALDH1A1 2612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.